Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 14, 2023
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
[ Tue, Feb 14th 2023
] - WOPRAI
Oren Livnat Maintained (CARA) at Strong Buy with Decreased Target to $25 on, Feb 14th, 2023
Oren Livnat of HC Wainwright & Co., Maintained "Cara Therapeutics, Inc." (CARA) at Strong Buy with Decreased Target from $30 to $25 on, Feb 14th, 2023.
Oren, nor any peers, have made any analyst calls on CARA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30